Intra-Cellular Therapies (NASDAQ:ITCI) Trading Up 6.7%
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report)’s stock price traded up 6.7% during trading on Tuesday . The stock traded as high as $49.48 and last traded at $49.46. 782,313 shares traded hands during trading, an increase of 4% from the average session volume of 752,862 shares. The stock had previously closed at $46.37. […]
More Stories
2,162 Shares in Astec Industries, Inc. (NASDAQ:ASTE) Bought by Point72 DIFC Ltd
Point72 DIFC Ltd bought a new stake in shares of Astec Industries, Inc. (NASDAQ:ASTE – Free Report) in the third...
Quarry LP Has $61,000 Stock Holdings in EverQuote, Inc. (NASDAQ:EVER)
Quarry LP increased its stake in EverQuote, Inc. (NASDAQ:EVER – Free Report) by 100.7% during the third quarter, Holdings Channel.com...
Asbury Automotive Group, Inc. (NYSE:ABG) Shares Sold by Quadrature Capital Ltd
Quadrature Capital Ltd lowered its position in Asbury Automotive Group, Inc. (NYSE:ABG – Free Report) by 71.2% during the 3rd...
State Street Corp Raises Holdings in Saia, Inc. (NASDAQ:SAIA)
State Street Corp boosted its position in Saia, Inc. (NASDAQ:SAIA – Free Report) by 3.1% during the third quarter, according...
Two Sigma Advisers LP Has $12.75 Million Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Two Sigma Advisers LP decreased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 21.8% in the third...
Two Sigma Advisers LP Has $10.12 Million Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN)
Two Sigma Advisers LP trimmed its position in shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) by 15.5% in...